A Guide to Investing in Gene Editing Stocks

June 15. 2020. 10 mins read

If we had to pick one disruptive technology that has the most potential to change mankind, it would be subset of nanotechnology called synthetic biology (or synbio). A critical component of synbio is gene editing. You cannot have one without the other. When many people first hear about the potential of gene editing, they want to invest in it. The goal of this guide is to make sure investors with no domain knowledge whatsoever are equipped with just the information they need to invest in pure-play gene-editing stocks.

What is Gene Editing?

Simply put, gene editing allows us to change the genetic makeup of organisms. Gene editing isn’t considered to be GMO because it’s a much more precise method of genetic engineering. One controversial use case is using gene editing on humans at the germline which means we can start to remove defects such as inherited diseases and (here’

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.